Announcement of TTY Biopharm's unaudited income information in November 2020 

2020.12.10

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2020/12/10 Time of announcement 14:30:24
Subject Announcement of TTY Biopharm's unaudited income information in November 2020
Date of events 2020/12/10 To which item it meets paragraph 53
Statement 1.Date of occurrence of the event:2020/12/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $313,221 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $45,971 thousands, and a consolidated income before tax of $50,423 thousands in November 2020; net income attributed to stockholders of the company was $39,167 thousands; EPS is $0.16.
Year-to-date consolidated net sales was $3,848,819 thousands (in NT dollars; unaudited), a consolidated operating profit was $878,667 thousands and consolidated income before tax was $1,041,379 thousands until November 2020; year-to-date net income attributed to stockholders of the company was $783,778 thousands; EPS is $3.15.
6.Countermeasures:N/A
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.
TOP